Zeuthen J - Search Results

1

Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules.

Andersen MH, Tan L, Søndergaard I, Zeuthen J, Elliott T, Haurum JS. Andersen MH, et al. Among authors: zeuthen j. Tissue Antigens. 2000 Jun;55(6):519-31. doi: 10.1034/j.1399-0039.2000.550603.x. Tissue Antigens. 2000. PMID: 10902608

2

An assay for peptide binding to HLA-Cw*0102.

Andersen MH, Søndergaard I, Zeuthen J, Elliott T, Haurum JS. Andersen MH, et al. Among authors: zeuthen j. Tissue Antigens. 1999 Aug;54(2):185-90. doi: 10.1034/j.1399-0039.1999.540210.x. Tissue Antigens. 1999. PMID: 10488746

3

Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.

Andersen MH, Bonfill JE, Neisig A, Arsequell G, Sondergaard I, Valencia G, Neefjes J, Zeuthen J, Elliott T, Haurum JS. Andersen MH, et al. Among authors: zeuthen j. J Immunol. 1999 Oct 1;163(7):3812-8. J Immunol. 1999. PMID: 10490979

4

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.

Berke Z, Andersen MH, Pedersen M, Fugger L, Zeuthen J, Haurum JS. Berke Z, et al. Among authors: zeuthen j. Leukemia. 2000 Mar;14(3):419-26. doi: 10.1038/sj.leu.2401703. Leukemia. 2000. PMID: 10720136

5

Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo.

Kastrup IB, Stevanovic S, Arsequell G, Valencia G, Zeuthen J, Rammensee HG, Elliott T, Haurum JS. Kastrup IB, et al. Among authors: zeuthen j. Tissue Antigens. 2000 Aug;56(2):129-35. doi: 10.1034/j.1399-0039.2000.560203.x. Tissue Antigens. 2000. PMID: 11019912

6

Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo.

Haurum JS, Høier IB, Arsequell G, Neisig A, Valencia G, Zeuthen J, Neefjes J, Elliott T. Haurum JS, et al. Among authors: zeuthen j. J Exp Med. 1999 Jul 5;190(1):145-50. doi: 10.1084/jem.190.1.145. J Exp Med. 1999. PMID: 10429679 Free PMC article.

7

A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses.

Olsen AC, Fossum B, Kirkin AF, Zeuthen J, Gaudernack G. Olsen AC, et al. Among authors: zeuthen j. Scand J Immunol. 1995 Apr;41(4):357-64. doi: 10.1111/j.1365-3083.1995.tb03579.x. Scand J Immunol. 1995. PMID: 7899823

8

Recognition of insulin on MHC-class-II-expressing L929 cells by antibody and T cells.

Rubin B, Malissen B, Jørgensen PN, Zeuthen J. Rubin B, et al. Among authors: zeuthen j. Res Immunol. 1989 Jan;140(1):67-74. doi: 10.1016/0923-2494(89)90007-2. Res Immunol. 1989. PMID: 2657910

9

The immunogenic properties of human melanomas and melanoma-associated antigens recognized by cytotoxic T lymphocytes.

Zeuthen J, Dzhandzhugazyan K, Hansen MR, Kirkin AF. Zeuthen J, et al. Bratisl Lek Listy. 1998 Aug-Sep;99(8-9):426-34. Bratisl Lek Listy. 1998. PMID: 9810766 Review.

10

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein.

Barfoed AM, Petersen TR, Kirkin AF, Thor Straten P, Claesson MH, Zeuthen J. Barfoed AM, et al. Among authors: zeuthen j. Scand J Immunol. 2000 Feb;51(2):128-33. doi: 10.1046/j.1365-3083.2000.00668.x. Scand J Immunol. 2000. PMID: 10652158 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters